| 995 |
HERMES-24 Score Derivation and Validation for Simple and Robust Outcome Prediction After Large Vessel Occlusion Treatment
|
2024-07-30 |
665 |
| 994 |
Dose Reduction of Edoxaban in Patients 80 Years and Older With Atrial Fibrillation Post Hoc Analysis of the ENGAGE AF-TIMI 48 Randomized Clinical Trial
|
2024-07-30 |
673 |
| 993 |
Tenecteplase for Ischemic Stroke at 4.5 to 24 Hours without Thrombectomy
|
2024-07-30 |
678 |
| 992 |
Recurrent Ischemic Stroke in Patients With Atrial Fibrillation While Receiving Oral Anticoagulants
|
2024-07-01 |
745 |
| 991 |
Reteplase versus Alteplase for Acute Ischemic Stroke
|
2024-07-01 |
765 |
| 990 |
Immediate- or Delayed-Intensive Statin in Acute Cerebral Ischemia
|
2024-07-01 |
535 |
| 989 |
Early vs Late Anticoagulation in Minor, Moderate, and Major Ischemic Stroke With Atrial Fibrillation: Post Hoc Analysis of the ELAN Randomized Clinical Trial
|
2024-05-31 |
699 |
| 988 |
Decompressive craniectomy plus best medical treatment versus best medical treatment alone for spontaneous severe deep supratentorial intracerebral haemorrhage: a randomised controlled clinical trial
|
2024-05-31 |
550 |
| 987 |
Trial of Thrombectomy for Stroke with a Large Infarct of Unrestricted Size
|
2024-05-31 |
534 |
| 986 |
Effects of Tirofiban on Neurological Deterioration in Patients With Acute Ischemic Stroke A Randomized Clinical Trial (TREND trial)
|
2024-04-30 |
830 |
| 985 |
Clopidogrel Plus Aspirin vs Aspirin Alone in Patients With Acute Mild to Moderate Stroke The ATAMIS Randomized Clinical Trial
|
2024-04-30 |
690 |
| 984 |
Antithrombotic Treatment for Stroke Prevention in Cervical Artery Dissection: The STOP-CAD Study
|
2024-04-30 |
691 |
| 983 |
Endovascular Treatment of Acute Ischemic Stroke After Cardiac Interventions in the United States
|
2024-02-29 |
915 |
| 982 |
Long-Term Resveratrol Intake for Cognitive and Cerebral Blood Flow Impairment in Carotid Artery Stenosis/Occlusion
|
2024-02-29 |
637 |
| 981 |
Safety and efficacy of platelet glycoprotein VI inhibition in acute ischaemic stroke (ACTIMIS): a randomised, doubleblind, placebo-controlled, phase 1b/2a trial
|
2024-02-29 |
739 |
HOME
LOGIN
